Predictive factors of Gleason score upgrading in localized and locally advanced prostate cancer diagnosed by prostate biopsy

Korean Journal of Urology

Volumn 51, Issue 10, 2010, Pages 677-682

  Moon, Seung Jin ^a   Park, Sung Yul ^a   Lee, Tchun Yong ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Biopsy; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; DIAGNOSTIC ACCURACY; GLEASON SCORE; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORGAN SIZE; PREOPERATIVE EVALUATION; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

EID: 78149349553     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2010.51.10.677     Document Type: Article

References (23)

1. Kim SC, Hong JH, Song K, Jeong IG, Song C, Kim CS, et al. Predictive factors for upgrading or upstaging in biopsy Gleason score 6 prostate cancer. Korean J Urol 2009;50:836-42.
2. Rubin MA, Bismar TA, Curtis S, Montie JE. Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients? Am J Surg Pathol 2004;28:946-52.
3. Patel AR, Jones JS. Optimal biopsy strategies for the diagnosis and staging of prostate cancer. Curr Opin Urol 2009;19:232-7.
4. Lim T, Park SC, Jeong YB, Kim HJ, Rim JS. Predictors of Gleason score upgrading after radical prostatectomy in low-risk prostate cancer. Korean J Urol 2009;50:1182-7.
5. Miyake H, Kurahashi T, Takenaka A, Hara I, Fujisawa M. Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores. Urol Int 2007;79:302-6.
6. Hong SK, Han BK, Lee ST, Kim SS, Min KE, Jeong SJ, et al. Prediction of Gleason score upgrading in low-risk prostate cancers diagnosed via mult (> or =12)-core prostate biopsy. World J Urol 2009;27:271-6.
7. Dong F, Jones JS, Stephenson AJ, Magi-Galluzzi C, Reuther AM, Klein EA. Prostate cancer volume at biopsy predicts clinically significant upgrading. J Urol 2008;179:896-900.
8. Kulkarni GS, Lockwood G, Evans A, Toi A, Trachtenberg J, Jewett MA, et al. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy. Cancer 2007;109:2432-8.
9. Freedland SJ, Kane CJ, Amling CL, Aronson WJ, Terris MK, Prest JC Jr. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. Urology 2007;69:495-9.
10. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994;271:368-74. (Pubitemid 24037911)
11. Carter HB, Allaf ME, Partin AW. Diagnosis and staging of prostate cancer. In: Wein AJ, Kavoussi LR, Norvick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007;2912-31.
12. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969-74.
13. Epstein JI, Partin AW, Sauvageot J, Walsh PC. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 1996;20:286-92.
14. Moussa AS, Li J, Soriano M, Klein EA, Dong F, Jones JS. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer. BJU Int 2009;103:43-8.
15. Montironi R, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Mikuz G, Algaba F, et al. Prostate carcinoma II: prognostic factors in prostate needle biopsies. BJU Int 2006;97:492-7.
16. Nayyar R, Singh P, Gupta NP, Hemal AK, Dogra PN, Seth A, et al. Upgrading of Gleason socre on radical prostatectomy specimen compared to the pre-operative needle core biopsy: an Indian experience. Indian J Urol 2010;26:56-9.
17. Tilki D, Schlenker B, John M, Buchner A, Stanislaus P, Gratzke C, et al. Clinical and pathological predictors of Gleason Sum upgrading in patients after radical prostatectomy: results from a single institution series. Urol Oncol 2009;Epub ahead of print
18. Turley RS, Hamilton RJ, Terris MK, Kane CJ, Aronson WJ, Presti JC Jr, et al. Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database. J Urol 2008;179:523-7.
19. Kassouf W, Nakanishi H, Ochiai A, Babaian KN, Troncoso P, Babaian RJ. Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies. J Urol 2007;178:111-4.
20. Kahl P, Wolf S, Adam A, Heukamp LC, Ellinger J, Vorreuther R, et al. Saturation biopsy improves preoperative Gleason scoring of prostate cancer. Pathol Res Pract 2009;205:259-64.
21. King CR, McNeal JE, Gill H, Presti JC Jr. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. Int J Radiat Oncol Biol Phys 2004;59:386-91.
22. San Francisco IF, DeWolf WC, Rosen S, Upton M, Olumi AF. Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J Urol 2003;169:136-40.
23. Takashima R, Egawa S, Kuwao S, Baba S. Anterior distribution of Stage T1c nonpalpable tumors in radical prostatectomy specimens. Urology 2002;59:692-7.